21
Pre-procedure testing
COR LOE Recommendations
1 A 1. In patients being considered for implantation of a CPP
device, a 12-lead ECG is recommended to evaluate the
heart rhythm, heart rate, AV conduction, and QRS
duration and morpholog y to determine the appropriate
type of CPP.
1 A
(CRT)
2. In patients planned to undergo implantation of a CPP
device, pre-procedural echocardiographic screening for
LVEF is recommended.
C-EO
(HBP,
LBBAP)
2b B-R 3. In patients indicated for CRT, use of an imaging modality
(eg, echocardiogram, cardiac MRI or CT) may be
considered to target LV lead placement.
3: No
Benefit
A 4. In patients being considered for CRT, pre-procedural
echocardiographic assessment of ventricular dyssynchrony is
not useful to predict outcomes from CRT with BiV pacing.
Shared decision-making
COR LOE Recommendation
1 C-EO 1. In patients who may benefit from CPP, clinicians and
patients should engage in a shared decision-making
approach in which (1) information is shared on the
evidence base for different types of CPP and (2) treatment
decisions are based not only on the best available evidence
but also on the patient's goals of care, preferences, and
values.
